{"id":"W4385856058","doi":"10.1097/01.hs9.0000971412.45898.1a","title":"P1129: GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): EXTENDED FOLLOW-UP AND LANDMARK ANALYSES FROM A PIVOTAL PHASE II STUDY","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Refractory (planetary science); Regimen; Post-hoc analysis; Internal medicine; Phases of clinical research; Clinical endpoint; Toxicity; Oncology; Nuclear medicine; Clinical trial; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001182309,0.0005458869,0.001237978,0.000192712,0.0001994338,0.0008937253,0.0004656987,0.0005277283,0.002251703],"category_scores_gemma":[0.000881694,0.0002384239,0.0008675432,0.0003537275,0.0003043225,0.0006280054,0.0004127763,0.0015951,0.0005710688],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005052126,"about_ca_system_score_gemma":0.0005181632,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004107949,"about_ca_topic_score_gemma":0.001325599,"domain_scores_codex":[0.9996186,0.00019935,0.00002388492,0.00006570504,0.00004324084,0.00004915068],"domain_scores_gemma":[0.9994609,0.0001027773,0.0001525784,0.00005503966,0.00004125002,0.0001874143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7068452,0.01139477,0.04691231,0.001453934,0.003013877,0.0005804225,0.0003371677,0.003588233,0.04288978,0.0002069611,0.01049061,0.1722867],"study_design_scores_gemma":[0.3434079,0.4060704,0.2224742,0.0001543382,0.002786396,0.001261194,0.0001459069,0.003042635,0.006093347,0.0003239287,0.01415199,0.00008781362],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930957,0.002568598,0.0003625428,0.0003182597,0.00005302402,0.00041923,0.001650546,0.00008432665,0.001447716],"genre_scores_gemma":[0.9920501,0.001007333,0.000621097,0.0003141105,0.00008692231,0.0003272259,0.004392583,0.00002252946,0.001178085],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002251703,"threshold_uncertainty_score":0.007532716,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02767289858449691,"score_gpt":0.3331577224684618,"score_spread":0.3054848238839649,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}